Brief: Aquestive Therapeutics, Inc. Q3 revenue USD 13.002 million
06/11/2023 21:41
Nov 6 (Reuters) - Aquestive Therapeutics, Inc. Q3 income from operations USD -2.377 million. * Q3 adjusted EBITDA USD -1.339 million * Q3 revenue USD 13.002 million vs. IBES estimate USD 11.5 million * Q3 pretax profit USD -2.175 million * Q3 net income USD -2.035 million
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma